Monte Rosa Therapeutics (GLUE) Shares Outstanding (Entity) (2020 - 2026)
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Monte Rosa Therapeutics | 1.40 Bn | 771.57 Mn | - | 85.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.23 Mn |
| Mar 31, 2026 | 84.32 Mn |
| Dec 31, 2025 | 83.07 Mn |
| Sep 30, 2025 | 82.40 Mn |
| Jun 30, 2025 | 82.19 Mn |
| Mar 31, 2025 | 82.15 Mn |
| Dec 31, 2024 | 61.51 Mn |
| Sep 30, 2024 | 82.01 Mn |
| Jun 30, 2024 | 61.33 Mn |
| Mar 31, 2024 | 50.20 Mn |
| Dec 31, 2023 | 50.14 Mn |
| Sep 30, 2023 | 50.07 Mn |
| Jun 30, 2023 | 49.59 Mn |
| Mar 31, 2023 | 49.36 Mn |
| Dec 31, 2022 | 49.32 Mn |
| Sep 30, 2022 | 48.37 Mn |
| Jun 30, 2022 | 46.68 Mn |
| Mar 31, 2022 | 46.63 Mn |
| Dec 31, 2021 | 25.00 Mn |
| Sep 30, 2021 | 46.48 Mn |